Answers are grounded in this paper and cite their sources.
To enhance our comprehension of the progression in the field of Chinese medicine for pulmonary fibrosis (PF), to grasp thefundamental shift in the understanding of role of Chinese medicine in PF management, to delve into potential and efficaciouspharmacological mechanisms for PF, and to uncover innovative diagnostic targets, we employed a bibliometric analysis to examinearticles pertaining to Chinese medicine for PF published between 2005 and 2023. Drawing upon information derived from the Webof Science Core Collection spanning the years 2005 to 2023, a thorough compilation of 389 articles focused on Chinese medicinefor PF has been identified, distributed across an array of 389 scholarly journals. These contributions were authored by 2334individuals associated with 395 organizations representing diverse regions, encompassing 16 distinct countries or territories. Ourfindings shed light on the evolution of traditional Chinese medicine's application and research in effective PF therapy, the evolvingparadigm guiding this domain, the exploration and integration of novel mechanisms, and the emerging frontiers within this realm.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: